Valuation: Novartis AG

Market Cap 278B 250B 233B 211B 397B 26,443B 399B 2,798B 1,093B 13,724B 1,043B 1,021B 44,140B P/E 2026 *
20.5x
P/E 2027 * 17.1x
Enterprise Value 309B 278B 260B 235B 442B 29,451B 445B 3,116B 1,217B 15,285B 1,162B 1,137B 49,162B EV / Sales 2026 *
5.37x
EV / Sales 2027 * 5x
Free-Float
91.66%
Yield 2026 *
2.96%
Yield 2027 * 3.09%
1 day+2.82%
1 week+2.20%
Current month+2.25%
1 month+7.67%
3 months+0.20%
6 months+1.98%
Current year+11.92%
1 week 118.44
Extreme 118.44
122.66
1 month 113.48
Extreme 113.48
122.66
Current year 107.68
Extreme 107.68
132.68
1 year 97.05
Extreme 97.05
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+2.82%+2.20%+17.90%+40.15% 272B
+3.62%+1.68%+48.80%+98.41% 1,040B
+2.13%-1.76%+33.04%+61.88% 599B
+3.32%+4.47%+23.72%+91.59% 485B
+3.80%+3.21%+73.99%+41.69% 350B
+3.09%+3.03%+29.59%+45.42% 345B
+3.40%+0.99%-3.44%+12.08% 244B
+3.21%+3.15%+45.01%+49.99% 223B
+3.80%+4.56%+29.59%+97.73% 183B
-0.27%+0.81%-29.03%-64.28% 170B
Average +2.69%+2.16%+26.92%+47.47% 391.28B
Weighted average by Cap. +2.53%+1.66%+33.93%+62.91%

Financials

2026 *2027 *
Net sales 57.66B 51.84B 48.38B 43.85B 82.32B 5,487B 82.83B 581B 227B 2,848B 216B 212B 9,159B 61.35B 55.16B 51.48B 46.65B 87.59B 5,838B 88.14B 618B 241B 3,030B 230B 225B 9,746B
Net income 14.59B 13.12B 12.24B 11.09B 20.83B 1,388B 20.96B 147B 57.35B 720B 54.76B 53.58B 2,317B 16.19B 14.56B 13.58B 12.31B 23.11B 1,541B 23.26B 163B 63.65B 800B 60.78B 59.46B 2,572B
Net Debt 31.62B 28.43B 26.53B 24.04B 45.14B 3,009B 45.42B 318B 124B 1,562B 119B 116B 5,022B 28.66B 25.77B 24.05B 21.79B 40.92B 2,727B 41.17B 289B 113B 1,415B 108B 105B 4,553B
Projected Income Statement - Annual - Novartis AG
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
14/10/26 CHF 122.66 +2.82% 2,668,527
13/10/26 CHF 119.30 -0.55% 3,008,571
12/10/26 CHF 119.96 +0.72% 2,107,041
09/10/26 CHF 119.10 +1.17% 1,772,212
08/10/26 CHF 117.72 -1.92% 3,863,359
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Novartis AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
146.19USD
Average target price
150.18USD
Spread / Average Target
+2.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novartis AG
  1. Stock Market
  2. Stocks
  3. NOVN Stock